0 NYSE Companies - May 9, 2024AEON Biopharma Provides Update on Development PipelineIRVINE, Calif., May 09, 2024 (GLOBE NEWSWIRE) — AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical […]Read More
0 NYSE Companies - May 9, 2024Rush Street Interactive to Participate at the Needham Technology, Media, & Consumer ConferenceCHICAGO, May 09, 2024 (GLOBE NEWSWIRE) — Rush Street Interactive, Inc. (NYSE: RSI) (“RSI”), a leading online casino and sports […]Read More
0 NYSE Companies - May 9, 2024Stryker declares a $0.80 per share quarterly dividendPortage, Michigan, May 09, 2024 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly […]Read More
0 Canadian Stock Exchange News - May 9, 2024Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University’s Institute for Psychedelic ResearchVANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health […]Read More
0 TSX News - May 9, 2024illumin Reports First Quarter 2024 Financial ResultsTotal First Quarter Revenue of $25.0 millionillumin Self-Service Revenue up 282% YoY (All monetary figures are expressed in Canadian dollars […]Read More
0 TSX News - May 9, 2024Knight Therapeutics Reports First Quarter 2024 ResultsMONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) […]Read More
0 TSX News - May 9, 2024Cronos Group Reports 2024 First Quarter ResultsIndustry-leading balance sheet with $855 million in cash and cash equivalents Net revenue in Q1 2024 increased by 30% year-over-year […]Read More
0 NYSE Companies - May 9, 2024Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s DiseaseMALVERN, Pa., May 09, 2024 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug […]Read More
0 NASDAQ Companies - May 9, 2024Vital Farms Reports First Quarter 2024 Financial ResultsRecord First Quarter Net Revenue of $147.9 million, up 24.1% versus Prior Year PeriodRaises Fiscal Year 2024 OutlookAnnounces Plans for […]Read More
0 NYSE Companies - May 9, 2024ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare ConferenceLAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) — ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive […]Read More